Siemens healthcare unit probed by China regulator for bribery: sources

Shanghai

A CHINESE regulator investigated Siemens AG last year over whether the German group's healthcare unit and its dealers bribed hospitals to buy expensive disposable products used in some of its medical devices, three people with knowledge of the probe told Reuters.

The investigation, which has not previously been reported, follows a wide-reaching probe into the pharmaceutical industry in China that last year saw GlaxoSmithKline fined nearly US$500 million for bribing officials to push its medicine sales.